Volume 4, Issue 14 (4-2014)                   NCMBJ 2014, 4(14): 47-50 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Koohi Moftakhari Esfahani M, Alavi S E, akbarzadeh A. Drug delivery of pegylated nanoliposomal paclitaxel to breast cancer cell line. NCMBJ 2014; 4 (14) :47-50
URL: http://ncmbjpiau.ir/article-1-518-en.html
Pilot, Biotechnology Department, Pasteur Institute of Iran, Tehran, Iran , s.ebrahimalavi@gmail.com
Abstract:   (16018 Views)
Aim and Background: Formulation of anticancer drugs aroused intensive research in the past decades. Pegylated nanoliposomes have been utilized as effective drug carriers, a vehicle for drug delivery. The aim of this study is to evaluate the performance of polyethylene glycol on the liposome structure. 
Materials and Methods: In order to produce pegylated nanoliposomal certain proportions of phosphatidylcholine, cholesterol, polyethylene glycol and paclitaxel were mixed together. The mean diameter of pegylated nanoliposomal paclitaxel was determined by Zeta sizer system. The encapsulation efficiency was calculated using standard curve. The percent of drug released from pegylated nanoliposomes was performed by dialysis for 28 hours. Also, cytotoxicity of pegylated nanoliposomal paclitaxel was studied through MTT technique. 
Results: The particles’ mean diameter confirmed in nano dimensions. Encapsulation efficiency and drug release of pegylated nanoliposomal paclitaxel was 95.2±6.3% and 5.02, respectively. Results showed an increase in toxicity, the formulation was prepared. 
Conclusion: Polyethylene glycol causes more stability and slower release of drug.
Full-Text [PDF 227 kb]   (4208 Downloads)    
Type of Study: Research Article | Subject: Cellular and molecular
Received: 2014/07/13 | Accepted: 2014/07/13 | Published: 2014/07/13

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb